{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:01:01Z","timestamp":1791414061648,"version":"4.3.3"},"reference-count":14,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T00:00:00Z","timestamp":1659916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.xkme.2022.100533","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T23:55:45Z","timestamp":1660262145000},"page":"100533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Sodium-Glucose Cotransporter 2 Inhibitors and Management of Refractory Hypomagnesemia Without Overt Urinary Magnesium Wasting: A Report of 2 Cases"],"prefix":"10.1016","volume":"4","author":[{"given":"Chintan V.","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Scott","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Sparks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xkme.2022.100533_bib1","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1080\/07853890.2020.1841281","article-title":"The expanding role of SGLT2 inhibitors beyond glucose-lowering to cardiorenal protection","volume":"53","author":"Brown","year":"2021","journal-title":"Ann Med"},{"issue":"12","key":"10.1016\/j.xkme.2022.100533_bib2","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1007\/s00125-016-4101-6","article-title":"Elevated serum magnesium associated with SGLT2 inhibitor use in type 2 diabetes patients: a meta-analysis of randomised controlled trials","volume":"59","author":"Tang","year":"2016","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.xkme.2022.100533_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2019.06.007","article-title":"Correction of hypomagnesemia by dapagliflozin in patients with type 2 diabetes: a post hoc analysis of 10 randomized, placebo-controlled trials","volume":"33","author":"Toto","year":"2019","journal-title":"J\u00a0Diabetes Complications"},{"issue":"3","key":"10.1016\/j.xkme.2022.100533_bib4","doi-asserted-by":"crossref","first-page":"477","DOI":"10.34067\/KID.0006672021","article-title":"Comparative effects of sodium-glucose cotransporter 2 inhibitors on serum electrolyte levels in patients with Type 2 diabetes: A pairwise and network meta-analysis of randomized controlled trials","volume":"3","author":"Zhang","year":"2022","journal-title":"Kidney360"},{"issue":"3","key":"10.1016\/j.xkme.2022.100533_bib5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.xkme.2020.01.010","article-title":"SGLT2 inhibitors for treatment of refractory hypomagnesemia: a case report of 3 patients","volume":"2","author":"Ray","year":"2020","journal-title":"Kidney Med"},{"issue":"2","key":"10.1016\/j.xkme.2022.100533_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.185","article-title":"Early initiation of sodium-glucose linked transporter inhibitors (SGLT-2i) and associated metabolic and electrolyte outcomes in diabetic kidney transplant recipients","volume":"4","author":"Song","year":"2020","journal-title":"Endocrinol Diab Metab"},{"issue":"23","key":"10.1016\/j.xkme.2022.100533_bib7","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1042\/CS20201274","article-title":"SGLT2 inhibition versus sulfonylurea treatment effects on electrolyte and acid-base balance: secondary analysis of a clinical trial reaching glycemic equipoise: tubular effects of SGLT2 inhibition in type 2 diabetes","volume":"134","author":"van Bommel","year":"2020","journal-title":"Clin Sci (Lond)"},{"issue":"1-2","key":"10.1016\/j.xkme.2022.100533_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1024\/0300-9831\/a000190","article-title":"Vitamin D supplementation and serum levels of magnesium and selenium in type 2 diabetes mellitus patients: gender dimorphic changes","volume":"84","author":"Al-Daghri","year":"2014","journal-title":"Int J Vitam Nutr Res"},{"issue":"8","key":"10.1016\/j.xkme.2022.100533_bib9","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.bbadis.2007.03.009","article-title":"TRPM6 and TRPM7\u2014gatekeepers of human magnesium metabolism","volume":"1772","author":"Schlingmann","year":"2007","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"10.1016\/j.xkme.2022.100533_bib10","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.bbadis.2007.02.001","article-title":"TRP channels in kidney disease","volume":"1772","author":"Hsu","year":"2007","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.xkme.2022.100533_bib11","doi-asserted-by":"crossref","first-page":"F1224","DOI":"10.1152\/ajprenal.00370.2019","article-title":"Renal SGLT mRNA expression in human health and disease: a study in two cohorts","volume":"317","author":"Srinivasan Sridhar","year":"2019","journal-title":"Am J Physiol Ren Physiol"},{"issue":"11","key":"10.1016\/j.xkme.2022.100533_bib12","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.3390\/nu13114088","article-title":"Effect of dapagliflozin and magnesium supplementation on renal magnesium handling and magnesium homeostasis in metabolic syndrome","volume":"13","author":"Ng","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.xkme.2022.100533_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/db15-1028","article-title":"Hypomagnesemia in type 2 diabetes: a vicious circle?","volume":"65","author":"Gommers","year":"2016","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.xkme.2022.100533_bib14","first-page":"315","article-title":"Fractional excretion of magnesium in normal subjects and in patients with hypomagnesemia","volume":"10","author":"Elisaf","year":"1997","journal-title":"Magnes Res"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059522001558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059522001558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:24:20Z","timestamp":1762910660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059522001558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":14,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2590059522001558"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2022.100533","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium-Glucose Cotransporter 2 Inhibitors and Management of Refractory Hypomagnesemia Without Overt Urinary Magnesium Wasting: A Report of 2 Cases","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2022.100533","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"100533"}}